Frontiers in Cellular Neuroscience,
Journal Year:
2024,
Volume and Issue:
18
Published: Oct. 30, 2024
Cochlear
ribbon
synapses
between
sensory
inner
hair
cells
(IHCs)
and
spiral
ganglion
neurons
(SGNs)
are
vulnerable
to
rapid
primary
damage
and/or
loss
due
noise
overexposure.
Such
damaged
can
repair
spontaneously
in
mouse
guinea
pig.
However,
the
mechanisms
for
synaptic
unclear.
Previously,
we
have
demonstrated
a
critical
role
fractalkine
signaling
axis
(CX
International Journal of Molecular Sciences,
Journal Year:
2023,
Volume and Issue:
24(22), P. 16545 - 16545
Published: Nov. 20, 2023
Cisplatin
is
a
commonly
used
chemotherapeutic
agent
with
proven
efficacy
in
treating
various
malignancies,
including
testicular,
ovarian,
cervical,
breast,
bladder,
head
and
neck,
lung
cancer.
also
to
treat
tumors
children,
such
as
neuroblastoma,
osteosarcoma,
hepatoblastoma.
However,
its
clinical
use
limited
by
severe
side
effects,
ototoxicity,
nephrotoxicity,
neurotoxicity,
hepatotoxicity,
gastrointestinal
toxicity,
retinal
toxicity.
Cisplatin-induced
ototoxicity
manifests
irreversible,
bilateral,
high-frequency
sensorineural
hearing
loss
40–60%
of
adults
up
60%
children.
Hearing
can
lead
social
isolation,
depression,
cognitive
decline
adults,
speech
language
developmental
delays
causes
hair
cell
death
forming
DNA
adducts,
mitochondrial
dysfunction,
oxidative
stress,
inflammation,
culminating
programmed
apoptosis,
necroptosis,
pyroptosis,
or
ferroptosis.
Contemporary
medical
interventions
for
cisplatin
are
prosthetic
devices,
aids,
but
these
have
significant
limitations
because
the
cochlea
remains
damaged.
Recently,
U.S.
Food
Drug
Administration
(FDA)
approved
first
therapy,
sodium
thiosulfate,
prevent
cisplatin-induced
pediatric
patients
localized,
non-metastatic
solid
tumors.
Other
pharmacological
treatments
stages
preclinical
development.
This
narrative
review
aims
highlight
molecular
mechanisms
involved
focusing
on
cochlear
shed
light
potential
antioxidant
anti-inflammatory
therapeutic
mitigate
ototoxic
effects
cisplatin.
We
conducted
comprehensive
literature
search
(Google
Scholar,
PubMed)
publications
last
five
years.
Hearing Research,
Journal Year:
2024,
Volume and Issue:
445, P. 108989 - 108989
Published: March 11, 2024
Age-related
hearing
loss
affects
a
large
and
growing
segment
of
the
population,
with
profound
impacts
on
quality
life.
pathology
cochlea-the
mammalian
organ-underlies
age-related
loss.
Because
investigating
changes
in
cochlea
humans
is
challenging
often
impossible,
animal
models
are
indispensable
to
investigate
these
mechanisms
as
well
complex
consequences
brain
behavior.
In
this
review,
we
advocate
for
comparative
interdisciplinary
approach
while
also
addressing
challenges
comparing
across
species
varying
lifespans.
We
describe
experimental
advantages
limitations
areas
future
research
well-established
loss,
including
mice,
rats,
gerbils,
chinchillas,
birds.
indicate
need
expand
characterization
other
established
models,
especially
guinea
pigs,
cats,
non-human
primates,
which
auditory
function
characterized
but
cochlear
understudied.
Finally,
highlight
potential
emerging
advancing
our
understanding
deer
their
notably
extended
lifespans
preserved
hearing,
naked
mole
exceptional
longevity
extensive
vocal
communications,
zebrafish,
offer
genetic
tractability
suitability
drug
screening.
Ultimately,
research,
combining
insights
from
various
human
studies,
key
robust
reliable
outcomes
that
better
advance
treatment
Cell Death and Disease,
Journal Year:
2025,
Volume and Issue:
16(1)
Published: Feb. 3, 2025
Abstract
According
to
the
World
Health
Organization,
more
than
12%
of
world’s
population
suffers
from
noise-induced
hearing
loss
(NIHL).
Oxidative
stress-mediated
damage
stria
vascularis
(SV)
is
one
pathogenic
mechanisms
NIHL.
Recent
studies
indicate
that
glycolysis
plays
a
critical
role
in
endothelial
cells
(ECs)-related
diseases.
However,
specific
dysfunction
SV-ECs
remain
largely
unknown.
In
this
study,
we
investigated
effects
on
vitro
and
SV
vivo.
Our
previous
research
identified
pathway
as
potential
mechanism
underlying
injuries
induced
by
oxidative
stress.
We
further
examined
expression
levels
glycolytic
genes
under
H
2
O
stimulation
noise-exposed
mice.
found
gene
protein
glycolytic-related
enzyme
LDHA
significantly
decreased
at
early
phase
after
stress
injury
both
vivo,
exhibited
anti-inflammatory
macrophages
(Mφ).
Moreover,
analyzed
differential
secretomes
with
without
inhibition
using
LC-MS/MS
technology,
identifying
CX3CL1
candidate
mediator
for
cellular
communication
between
Mφ.
secretion
was
following
Mφ
via
CX3CR1
pathway.
Similarly,
pro-inflammatory
effect
LDHA-overexpressing
attenuated
CX3CL1.
conclusion,
our
study
revealed
glycolysis-related
reduced
stress-induced
SV-ECs,
elicited
Mφ,
least
partially
through
CX3CL1-CX3CR1
These
findings
suggest
represent
novel
therapeutic
strategy
treatment
Ageing & Longevity,
Journal Year:
2025,
Volume and Issue:
1.2025, P. 69 - 72
Published: Feb. 20, 2025
Age-related
hearing
loss
(ARHL)
is
a
growing
global
healthcare
challenge.
An
increasing
body
of
research
suggests
an
association
between
ARHL
and
conditions
such
as
dementia,
hypertension,
diabetes,
obesity.
However,
the
causal
relationships
these
pathologies
remain
poorly
understood.
We
propose
that
vascular
pathology
may
be
key
pathogenetic
link
connecting
conditions,
particularly
given
inherent
vulnerability
cochlear
blood
supply
microvasculature.
One
promising
approach
for
studying
in
ageing
cochlea
involves
combining
optical
tissue
clearing,
light-sheet
microscopy,
advanced
3D
network
analysis.
This
enables
comprehensive
assessment
its
spatial
mapping
onto
other
structures.
To
fully
disentangle
factors
contributing
to
ARHL,
this
should
integrated
into
extensive,
systematic
animal
studies,
incorporating
models
ageing,
noise
exposure,
ARHL-related
comorbidities
combination
isolation.
Keywords:
age-related
loss;
sensorineural
metabolic
cochlea;
vasculature;
pathology;
stria
vascularis
Proceedings of the National Academy of Sciences,
Journal Year:
2025,
Volume and Issue:
122(11)
Published: March 11, 2025
Inflammation
is
among
the
known
causes
of
cisplatin-induced
hearing
loss
(CIHL),
but
its
exact
pathophysiological
mechanisms
remain
unclear.
Herein,
we
demonstrated
that
pyroptosis—a
recently
identified
inflammatory
type
regulated
cell
death
dependent
on
gasdermin
D
(GSDMD)—was
activated
in
cochleae
cisplatin-treated
mice,
causing
CIHL.
Meanwhile,
treatment
with
GSDMD
inhibitor
necrosulfonamide
alleviated
CIHL
these
mice.
To
further
examine
role
GSDMD-mediated
pyroptosis
CIHL,
conducted
experiments
Gsdmd-
deficient
mice
.
Gsdmd
−/−
significantly
lower
cochlear
damage
than
control
and
appeared
to
be
invulnerable
Furthermore,
stria
vascularis
(SV),
not
hair
cells
(HCs),
played
a
dominant
In
marginal
(MCs)
SV,
cisplatin
induced
caspase-dependent
cleavage,
pore-forming
N-terminal
rapidly
localized
mitochondria,
leading
abnormal
mitochondrial
aggregation
oxidative
stress.
The
consequent
dysfunction
MCs
might
result
severe
progression
inflammation,
SV
damage,
HC
loss.
Notably,
pharmacological
inhibition
using
FDA-approved
drug
disulfiram
effectively
symptoms
Collectively,
findings
offer
broad
avenue
for
inhibiting
pyroptosis-induced
ototoxicity
provide
valuable
theoretical
insights
clinical
management
International Journal of Molecular Sciences,
Journal Year:
2024,
Volume and Issue:
25(10), P. 5391 - 5391
Published: May 15, 2024
Age-related
hearing
loss
(HL),
or
presbycusis,
is
a
complex
and
heterogeneous
condition,
affecting
significant
portion
of
older
adults
involving
various
interacting
mechanisms.
Metabolic
type
age-related
HL,
characterized
by
the
dysfunction
stria
vascularis,
which
crucial
for
maintaining
endocochlear
potential
necessary
hearing.
Although
attention
on
metabolic
presbycusis
has
waned
in
recent
years,
research
continues
to
identify
strial
pathology
as
key
factor
HL.
This
narrative
review
integrates
past
research,
bridging
findings
from
animal
models
human
studies,
examine
contributions
vascularis
It
provides
brief
overview
structure
function
then
examines
mechanisms
contributing
dysfunction,
including
altered
ion
transport,
changes
pigmentation,
inflammatory
responses,
vascular
atrophy.
Importantly,
this
outlines
contribution
highlighting
areas
future
research.
emphasizes
interdependence
sensorineural
HL
highlights
importance
understanding
underlying
The
comprehensive
mechanistic
investigation
all
factors
cochlear
remains
identifying
developing
personalized,
protective,
restorative
treatments.
iScience,
Journal Year:
2025,
Volume and Issue:
28(2), P. 111832 - 111832
Published: Jan. 18, 2025
The
stria
vascularis
(SV)
is
an
essential
component
of
the
inner
ear
that
regulates
ionic
environment
required
for
hearing.
SV
degeneration
disrupts
cochlear
homeostasis,
leading
to
irreversible
hearing
loss,
yet
a
comprehensive
understanding
SV,
and
consequently
therapeutic
availability
degeneration,
lacking.
We
developed
whole-tissue
explant
model
from
neonatal
mature
mice
create
platform
advancing
research.
validated
our
by
demonstrating
proliferative
behavior
in
vitro
mimics
vivo.
also
provided
evidence
pharmacological
experimentation
investigating
role
Wnt/β-catenin
signaling
proliferation.
Finally,
we
performed
single-cell
RNA
sequencing
vivo
mouse
surrounding
tissue
revealed
key
genes
pathways
may
play
proliferation
maintenance.
Together,
results
contribute
new
insights
into
biological
solutions
SV-associated
loss.
Advanced Science,
Journal Year:
2025,
Volume and Issue:
unknown
Published: March 5, 2025
Certain
medications,
including
cisplatin
and
neomycin,
often
cause
both
hearing
loss
renal
dysfunction.
This
study
aims
to
uncover
the
common
mechanisms
behind
drug-induced
ototoxicity
nephrotoxicity
aid
early
diagnosis
treatment.
Metabolomic
analyses
reveal
simultaneous
disruptions
in
endogenous
metabolic
networks
kidney,
inner
ear,
serum
after
administrating
or
neomycin.
Notably,
a
marked
elevation
uric
acid
(UA),
recognized
indicator
of
tubular
injury,
is
identified.
Supplementing
UA
inhibiting
its
excretion
worsen
hair
cell
damage.
Single-cell
nucleus
sequencing
immunohistochemistry
major
changes
xanthine
oxidase
ABCG2,
crucial
for
metabolism,
primarily
cochlear
stria
vascularis
cells
rather
than
cells.
Cisplatin
triggers
significant
release
from
cells,
reaching
concentrations
sufficient
induce
autophagy-dependent
ferroptosis
In
coculture
system,
targeted
interventions
against
these
two
proteins
through
either
pharmacological
inhibition
genetic
manipulation,
markedly
decrease
elevated
subsequent
These
findings
suggest
connection
between
ear
highlighting
therapeutic
potential
modulating
mitigate
ototoxicity.